FDA Inspection
Edge Pharma, LLCEdge Pharma, LLC – FDA Inspection, Aug 20, 2014
Record Details
This FDA Inspection record concerns Edge Pharma, LLC, with an inspection on August 20, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Edge Pharma, LLC
- Inspection Date
- August 20, 2014
- Product Type
- Drugs
View Company Profile
ID · 6a4e8ccc-a7e7-4110-b31d-38523964be4e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 893817
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Edge Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 30, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Edge Pharma, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.